GlaxoSmithKline Pharmaceuticals has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) alleging overcharging of ₹3.54 crores. The company stated on June 25, 2026, that the demand includes ₹1.23 crores towards the alleged overcharging amount and ₹2.31 crores as interest. GlaxoSmithKline Pharmaceuticals clarified that the order will have no impact on its financial operations and confirmed it will file an appeal against the demand.

Demand Notice Details

The notice, dated June 24, 2026, alleges that the company overcharged in the sale of scheduled formulations by fixing prices higher than those notified by the government or the NPPA. The breakdown of the total demand is detailed below:

Regulatory Implications

The demand notice was issued under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific violation cited involves charging prices higher than the fixed or notified government price during the relevant period. The company has disclosed that it intends to challenge the order through an appeal.

GlaxoSmithKline Pharmaceuticals Limited has fixed Tuesday, June 23, 2026, as the record date to determine shareholder eligibility for the 101st Annual General Meeting (AGM). The AGM is scheduled for Tuesday, June 30, 2026, at 11.00 a.m. via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The company reported a revenue of ₹3,790 crore for FY26, a 2% increase from the previous year, with Profit After Tax (PAT) excluding exceptional items crossing ₹1,010 crore for the first time.

The meeting will be conducted without a physical venue in compliance with the Companies Act, 2013, and relevant SEBI (Listing Obligations and Disclosure Requirements) Regulations. Shareholders participating through VC/OAVM will be counted for quorum purposes under Section 103 of the Companies Act, 2013. The Annual Report for the Financial Year 2025-26 has been sent electronically to shareholders with registered email addresses, with a letter dispatched on June 6, 2026.

Remote E-Voting Schedule

Remote e-voting will commence at 9.00 a.m. on Friday, June 26, 2026, and conclude at 5.00 p.m. on Monday, June 29, 2026. Shareholders holding shares as of the cut-off date, Tuesday, June 23, 2026, are eligible to vote. The facility is provided by NSDL.

Business to be Transacted

The Board has proposed the ratification of remuneration for Cost Auditor R. Nanabhoy & Company. The fees for auditing cost records are set at ₹8.02 Lakhs for the year ended March 31, 2026, and ₹8.42 Lakhs for the year ending March 31, 2027, exclusive of taxes and out-of-pocket expenses. Additionally, the company seeks shareholder approval to pay commission to non-Whole-time Directors for a five-year period from April 1, 2026, to March 31, 2031, subject to a ceiling of 1% of net profits.

Pursuant to SEBI directives effective November 18, 2025, dividend payments will be processed exclusively in electronic mode, discontinuing the use of dividend warrants or cheques. Shareholders holding shares in dematerialized form must update details with their Depository Participant, while those with physical holdings must submit the prescribed ISR-1 form to KFin Technologies Limited. The company has advised members to register or update email addresses and bank account mandates to ensure timely receipt of payouts.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE159A01016/689c24a13dc3460f.pdf